 |
|
|
| |
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS
NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN IN MAINTAINING VIROLOGIC SUPPRESSION THROUGH 144 WEEKS (TANGO STUDY)
|
| |
| |
IDWeek 2021 Sept 29-Oct 3
Olayemi Osiyemi,1 Faïza Ajana,2 Fiona Bisshop,3 Stephane De Wit,4 Joaquín Portilla,5 Jean-Pierre Routy,6 Christoph Wyen,7 Mounir Ait-Khaled,8 Keith A. Pappa,9 Ruolan Wang,9 Peter A. Leone,9 Jonathan Wright,10 Brian Wynne,9 Jean van Wyk,8 Michael Aboud,8 Kimberly Y. Smith9
1Triple O Research Institute PA, West Palm Beach, FL, USA; 2Centre Hospitalier de Tourcoing, Tourcoing, France; 3Holdsworth House Medical Brisbane, Queensland, Australia; 4CHU St-Pierre, Brussels, Belgium; 5Hospital General Universitario de Alicante, Alicante, Spain; 6McGill University Health Centre, Montreal, QC, Canada; 7Praxis am Ebertplatz, Cologne, Germany; 8ViiV Healthcare, Brentford, UK; 9ViiV Healthcare, Research Triangle Park, NC, USA; 10GlaxoSmithKline, Brentford, UK
Updated. Correction to lipids section....
|
| |
|
|
|
|
|
